Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Valeant: Ready To Leap Long-Term On Latest Acquisition
Seeking Alpha
Friday, September 14, 2012 - 11:57am
tags:
M&A, Valeant Pharmaceuticals, Medicis, Teva Pharmaceuticals, Watson Pharmaceuticals
Fast-growing generics maker Perrigo moves into pet care
Fierce Pharma
Friday, September 14, 2012 - 11:55am
tags:
Perrigo, M&A
Boehringer Ingelheim lets Facebook game loose
Fierce Pharma
Friday, September 14, 2012 - 11:54am
tags:
Boehringer Ingelheim, social media, Facebook, Syrum
Pharmaceutical giant Merck & Co. to leave ALEC
Newark Star-Ledger, NJ
Friday, September 14, 2012 - 11:53am
tags:
Merck, ALEC
American drug firm Mylan in talks for a juicy piece of SMS Pharma
Financial Express, India
Friday, September 14, 2012 - 11:52am
tags:
Mylan, India, SMS Pharma, M&A
Biogen Sells Benlysta Rights
Yahoo/Zacks
Friday, September 14, 2012 - 11:51am
tags:
Biogen, Benlysta, GSK
Impax says its generic version of Concerta will go on sale in July 2013 in settlement with J&J
Yahoo/AP
Friday, September 14, 2012 - 11:49am
tags:
Impax, generics, Concerta, JNJ, ADHD, Teva Pharmaceuticals
Don't Get Too Worked Up Over Simcere Pharmaceutical Group's Earnings
Motley Fool
Friday, September 14, 2012 - 11:32am
tags:
earnings, Simcere
Biotechs Treating Incurable Disease Warrant Early Look
Seeking Alpha
Friday, September 14, 2012 - 11:31am
tags:
Acadia, Arthersys, Neurostem, Opexa, Sanofi
Is Dynavax an Underdog -- or Just a Dog?
Motley Fool
Friday, September 14, 2012 - 10:40am
tags:
Dynavax
Why Pfizer, Lilly Are Both Buys
Motley Fool
Friday, September 14, 2012 - 10:40am
tags:
Pfizer, Eli Lilly
Bayer buying Teva's US animal health business
Yahoo/AP
Friday, September 14, 2012 - 10:27am
tags:
Teva Pharmaceuticals, animal health, M&A, Bayer
Cornerstone Therapeutics says FDA advisers recommend against approving its drug lixivaptan
Yahoo/AP
Thursday, September 13, 2012 - 4:10pm
tags:
Cornerstone Therapeutics, FDA, advisory panel, hyponatremia, lixivaptan
NPS Pharmaceuticals Advances on Both Sides of the Atlantic
Motley Fool
Thursday, September 13, 2012 - 4:07pm
tags:
NPS Pharmaceuticals, Europe, teduglutide, short bowel syndrome
Vical's Vaxfectin Comes Alive
Seeking Alpha
Thursday, September 13, 2012 - 4:03pm
tags:
Vaxfectin, Vical, Bristol-Myers Squibb, metastatic melanoma
Seven reasons to buy DUSA Pharmaceuticals
Seeking Alpha
Thursday, September 13, 2012 - 10:53am
tags:
DUSA pharmaceuticals, Levulan photodynamic therapy, dermatology
J&J Shopping Reach Dental Products Business
WSJ Online
Thursday, September 13, 2012 - 10:48am
tags:
JNJ, dental, Reach Dental
GW Pharma IDs promising epilepsy drug in cannabis
Fierce Biotech
Thursday, September 13, 2012 - 10:45am
tags:
GW Pharma, epilepsy, cannabis
Pluristem prices public offering of 8 mln units at $4/shr
Reuters
Thursday, September 13, 2012 - 10:43am
tags:
stock offering, Pluristem
Merck, Simcere JV starts operations
China Daily
Thursday, September 13, 2012 - 10:26am
tags:
China, Merck, Simcere

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.